Guilbault Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
2,292
-126
-5% -$58.1K 1.22% 22
2026
Q1
$1.16M Sell
2,418
-146
-6% -$74.8K 1.27% 20
2025
Q4
$1.44M Buy
+2,564
New +$1.46M 1.61% 20

Other funds holding MEDP

Guilbault Capital's MEDP Position: Q2 2026 in Review

Guilbault Capital reduced its Medpace (MEDP) stake by 5.2% in Q2 2026, selling an estimated $58.1K and leaving 2,292 shares worth $1.21M. The position accounts for 1.22% of the portfolio, ranked #22.

Guilbault Capital first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.44M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Guilbault Capital held 2,292 shares of Medpace worth $1.21M as of Q2 2026.
  • Guilbault Capital sold 126 Medpace shares in Q2 2026, an estimated $58.1K.
  • Medpace made up 1.22% of Guilbault Capital's portfolio in Q2 2026, its #22 holding.
  • Guilbault Capital first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Guilbault Capital's Medpace position peaked at $1.44M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Guilbault Capital's 13F filing for Q2 2026, filed 23 Jul 2026.